Recombinant Human TGF-beta 1 Avi-tag Protein, CF

Name: Recombinant Human TGF-beta 1 Avi-tag Protein, CF
Brand: R&D Systems
SKU: AVI7754
Price: 1110 USD
Availability: InStock

R&D Systems | Catalog # AVI7754

Submit a review

Product Documents

Biotinylated

100% Guarantee

Product Specifications
Scientific Data
Preparation & Storage
Calculators
Background
Product Documents
Specific Notices
Research Areas

Key Product Details

R&D Systems HEK293-derived Recombinant Human TGF-beta 1 Avi-tag Protein (AVI7754)
Quality control testing to verify active proteins with lot specific assays by in-house scientists
All R&D Systems proteins are covered with a 100% guarantee

Source

HEK293

Accession Number

NP_000651.3

Structure / Form

Disulfide-linked homodimer, biotinylated via Avi-tag

Conjugate

Biotin

Applications

Bioactivity

View all TGF-beta 1 Proteins and Enzymes »

Learn more about Avi-tag Biotinylated Proteins

Product Specifications

Source

Human embryonic kidney cell, HEK293-derived human TGF-beta 1 protein

Avi-tag	Human TGF-beta 1 (Ala279-Ser390) Accession # NP_000651.3
N-terminus		C-terminus

Purity

>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Gly of Avi-tag

Predicted Molecular Mass

15 kDa

SDS-PAGE

12-16 kDa, under reducing conditions

Activity

The biotin to protein ratio is greater than 0.7 as determined by the HABA assay.

Measured by its binding ability in a functional ELISA.
When Recombinant Human TGF-beta RII Fc Chimera (Catalog # 341-BR) is immobilized at 0.1 µg/mL (100 µL/well), Biotinylated Recombinant Human TGF-beta 1 Avi-tag (Catalog # AVI7754) binds with an ED₅₀ of 0.80-6.40 ng/mL.

Scientific Data Images for Recombinant Human TGF-beta 1 Avi-tag Protein, CF

Biotinylated Recombinant Human TGF-beta 1 Avi-tag Protein Binding Activity

When Recombinant Human TGF-beta RII Fc Chimera (341-BR) is immobilized at 0.1 µg/mL (100 µL/well), Biotinylated Recombinant Human TGF-beta 1 Avi-tag (Catalog # AVI7754) binds with an ED₅₀ of 0.80-6.40 ng/mL.

Formulation, Preparation, and Storage

AVI7754

Formulation	Lyophilized from a 0.2 μm filtered solution in HCl with Trehalose.
Reconstitution	Reconstitute at 250 μg/mL in sterile 4 mM HCl.
Shipping	The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Background: TGF-beta 1

TGF-beta 1 (transforming growth factor beta 1) is one of three closely related mammalian members of the large TGF-beta superfamily that share a characteristic cystine knot structure (1-7). TGF-beta 1, -2 and -3 are highly pleiotropic cytokines that are proposed to act as cellular switches that regulate processes such as immune function, proliferation and epithelial-mesenchymal transition (1-4). Each TGF-beta isoform has some non-redundant functions; for TGF-beta 1, mice with targeted deletion show defects in hematopoiesis and endothelial differentiation, and die of overwhelming inflammation (2). Human TGF‑beta 1 cDNA encodes a 390 amino acid (aa) precursor that contains a 29 aa signal peptide and a 361 aa proprotein (8). A furin‑like convertase processes the proprotein to generate an N-terminal 249 aa latency‑associated peptide (LAP) and a C‑terminal 112 aa mature TGF‑beta 1 (8, 9). Disulfide‑linked homodimers of LAP and TGF‑beta 1 remain non-covalently associated after secretion, forming the small latent TGF‑beta 1 complex (8‑10). Covalent linkage of LAP to one of three latent TGF‑beta binding proteins (LTBPs) creates a large latent complex that may interact with the extracellular matrix (9, 10). TGF‑beta is activated from latency by pathways that include actions of the protease plasmin, matrix metalloproteases, thrombospondin 1 and a subset of integrins (10). Mature human TGF‑beta 1 shares 100% aa identity with pig, dog and cow TGF‑beta 1, and 99% aa identity with mouse, rat and horse TGF-beta 1. It demonstrates cross‑species activity (1). TGF‑beta 1 signaling begins with high‑affinity binding to a type II ser/thr kinase receptor termed TGF‑beta RII. This receptor then phosphorylates and activates a second ser/thr kinase receptor, TGF‑beta RI (also called activin receptor‑like kinase (ALK) ‑5), or alternatively, ALK‑1. This complex phosphorylates and activates Smad proteins that regulate transcription (3, 11, 12). Contributions of the accessory receptors betaglycan (also known as TGF‑beta RIII) and endoglin, or use of Smad‑independent signaling pathways, allow for disparate actions observed in response to TGF‑beta in different contexts (11). Our Avi-tag Biotinylated TGF-beta 1 features biotinylation at a single site contained within the Avi-tag, a unique 15 amino acid peptide. Protein orientation will be uniform when bound to streptavidin-coated surface due to the precise control of biotinylation and the rest of the protein is unchanged so there is no interference in the protein's bioactivity.